ChiCTR-TRC-14004839
尚未开始
/
/
/
2014-09-21
/
/
近視
青光眼藥物治療用於控制近視LASIK術後回退的功效及安全性隨機對照臨床試驗
青光眼藥物治療用於控制近視LASIK術後回退的功效及安全性隨機對照臨床試驗
青光眼藥物治療用於控制近視LASIK術後回退的功效及安全性
随机平行对照
Ⅳ期
Random
/
Department of Ophthalmology Visual Sciences, The Chinese University of Hong Kong
/
87
/
1990-01-01
1990-01-01
/
1. Patients with myopia or myopic astigmatism aged 21 years or more; 2. Anisometropia < 1 diopter.；
登录查看1. Patients aged < 21 years; 2. Patients in which the target refraction is not emmetropia; 3. Patients with ocular inflammation, diabetes mellitus, connective tissue disorders; 4. Patients who have used retinoid acid or equivalent in the past 6 months; 5. Patients with known cardiac disease or bronchial asthma.；
登录查看Department of Ophthalmology Visual Sciences, the Chinese University of Hong Kong
/
Insight数据库2024-10-25
中国上海自贸试验区2024-10-25
癌度2024-10-25
抗体圈2024-10-25
思路迪医药 3D Medicines2024-10-25
求实药社2024-10-25
药研网2024-10-25
凯莱英药闻2024-10-25
药精通Bio2024-10-25
细胞与基因治疗领域2024-10-25
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息
友情链接: 摩熵医药 摩熵医药企业版 摩熵化学MolAid 晓材Matmole 摩熵医学MedXYZ 载体质粒 觅健肿瘤互助 动脉网 药物百科
